Amedisys (AMED) PT Lowered to $255 at Jefferies on Hospice Weakness
Tweet Send to a Friend
Jefferies analyst Brian Tanquilut lowered the price target on Amedisys (NASDAQ: AMED) to $255.00 (from $340.00) after challenges faced by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
